Registry following adults with atrial fibrillation treated with the Globe pulsed field system
Collects real-world information on the Globe device used to treat atrial fibrillation in adults.
Plain-language title generated from the registry record
Registry title: Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
Key facts
- Where
- Bellevue and Jonesboro, United StatesSee the 2 sites
Where in United States
- Overlake HospitalBellevue, United StatesTaking people
- Arrhythmia Research GroupJonesboro, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Kardium Inc.
- Trial code
- NCT07651852
- Record updated
- 26 October 2026
- Original description
This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).Read full original descriptionShow less
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).
Inclusion: Patients with a planned ablation procedure using the commercially available Globe PF System.
Exclusion: Current enrollment in any investigational study of a medical device, biologic, or drug not pre-approved by Kardium; Patients whose life expectancy is 1 year or less; Contraindication to left atrial catheter ablation or PF ablation.